Stroke: History and Discovery

For more than two thousand years a sudden collapse into paralysis or coma was called apoplexy — from the Greek apoplexia, “to be struck down with violence.” To the ancients and to early-modern Europeans alike, the victim seemed felled by an invisible hand, an idea preserved in the English word stroke (the “stroke of God’s hand”). The turning point came in 1658, when the Swiss physician Johann Jakob Wepfer opened the skulls of people who had died of apoplexy and showed that the cause lay in the blood vessels of the brain — either bleeding into the brain or blockage of its arteries. From Wepfer’s autopsies through Thomas Willis’s map of the brain’s circulation, Rudolf Virchow’s account of thrombosis and embolism, the CT scanner, and the clot-dissolving drug tPA, this is the story of how a divine mystery became a treatable medical emergency in which “time is brain.”

Table of Contents

  1. Apoplexy: “Struck Down With Violence”
  2. Hippocrates and the Ancient Clinical Picture
  3. Wepfer 1658: Apoplexy Becomes a Disease of Blood Vessels
  4. Thomas Willis and the Circle of Willis
  5. Virchow: Thrombosis, Embolism, and the Modern Mechanism
  6. From “Apoplexy” to “Stroke” and “CVA”
  7. The Imaging Revolution: CT, MRI, and the Two Strokes
  8. Clot-Busters and “Time Is Brain”
  9. Legacy: From Divine Blow to Treatable Emergency
  10. Research Papers and References
  11. Connections

Apoplexy: “Struck Down With Violence”

The oldest name for stroke is apoplexy, an English rendering of the ancient Greek apoplexia (αποπληξία), built from apo- (“off, away”) and plessein (“to strike”). Literally it meant “to be struck down with violence,” and it captured exactly what observers could see: a person, often previously well, who suddenly fell senseless and paralysed as though knocked flat by an unseen force. The word first appears in the writings attributed to Hippocrates and his school in the fifth and fourth centuries BCE, and it remained the standard medical term in Europe for well over two thousand years.

It is important to be precise about what “apoplexy” did and did not mean, because the ancient term and the modern one are not simply the same idea in older words. Apoplexy was a clinical description — sudden collapse, loss of consciousness, loss of movement — not an explanation. The ancients had no concept of the brain’s blood supply failing; they could not see inside the living skull, and the underlying machinery was entirely hidden from them. Over the centuries “apoplexy” was therefore applied to a grab-bag of sudden fatal or near-fatal events, only some of which we would now recognise as cerebrovascular disease. Reading it as the exact equivalent of today’s “stroke” is an anachronism worth resisting.

What the ancients explained well was the experience, not the cause. In the prevailing humoral medicine, apoplexy was usually attributed to an excess or obstruction of phlegm or black bile choking the vital spirits, or to a blockage of the body’s “animal spirits” in the brain’s ventricles. These frameworks were wrong about mechanism, but the careful bedside observation of the apoplectic patient — the abrupt onset, the one-sided weakness, the deep unresponsiveness — was acute, and those clinical descriptions are recognisable to any modern stroke physician.

Back to Table of Contents

Hippocrates and the Ancient Clinical Picture

The Hippocratic corpus — the body of medical writings associated with Hippocrates of Cos (traditionally c. 460–c. 370 BCE) and his followers — contains the earliest surviving descriptions of what we would call stroke. The Hippocratic authors used the term apoplexia and noted, with characteristic caution, that the condition was difficult to treat and often fatal: a famous aphorism warns that it is impossible to cure a severe attack of apoplexy and difficult to cure a mild one. They also described the sudden, profound loss of speech and movement that defined the syndrome.

Remarkably, some Hippocratic and later Greek observations brush against the role of the neck arteries. The Greeks even named the great vessels of the neck the karotides — the source of our word carotid — from a root meaning “to stupefy” or “to plunge into deep sleep,” reflecting the ancient observation that pressure on these vessels could render a person unconscious. This is a striking hint, but it should not be over-read as knowledge of cerebral circulation: the ancients linked the neck vessels to sleep and stupor, not to a vascular supply that, when interrupted, kills brain tissue. That deeper understanding lay two millennia in the future.

The Greco-Roman physician Galen of Pergamon (129–c. 216 CE), whose authority dominated European medicine until the Renaissance, systematised apoplexy within humoral theory, generally attributing it to phlegm or black bile obstructing the flow of vital and animal spirits through the brain’s ventricles. Galen’s framework, transmitted through Byzantine, Arabic, and medieval Latin medicine, fixed apoplexy as a disease of obstructed spirits in the ventricular system — a model that was internally coherent, enormously influential, and fundamentally mistaken about where the problem lay. Dislodging it would require not a new theory but a new method: cutting open the dead to find out what had actually happened inside.

Back to Table of Contents

Wepfer 1658: Apoplexy Becomes a Disease of Blood Vessels

The decisive break with the ancient view came from Johann Jakob Wepfer (1620–1695), a physician and pathologist of Schaffhausen in Switzerland. In 1658 he published Historiae Apoplecticorum (often rendered as Observationes Anatomicae ex Cadaveribus eorum quos sustulit Apoplexia, “Anatomical observations from the bodies of those carried off by apoplexy”). In it he reported the careful dissection of several patients who had died of apoplexy and drew a conclusion that overturned more than a thousand years of doctrine: apoplexy was not a disorder of phlegm in the ventricles but a disorder of the brain’s blood vessels.

Wepfer’s autopsies showed two distinct vascular mechanisms, and this dual insight is the heart of his achievement. In some cases he found bleeding into or around the brain — blood that had escaped from a ruptured vessel, including a case he attributed to rupture of an artery — the lesion we now call hemorrhagic stroke. In other cases, where no hemorrhage was present, he reasoned that the apoplexy must have been caused by obstruction of the vessels carrying blood to the brain, cutting off its supply — an early conception of what we now call ischemic stroke or cerebral infarction. Linking the clinical event at the bedside to a specific abnormality in the cerebral vasculature was the conceptual leap that founded the modern understanding of stroke.

Wepfer was also a meticulous anatomist of the relevant plumbing. He described the arteries that supply the brain — the internal carotid and vertebral arteries and their branches — and traced their course, work that anticipated by several years the more celebrated synthesis of Thomas Willis. His thinking fit the new circulatory physiology of his era: William Harvey had demonstrated the circulation of the blood in 1628, and Wepfer’s account of a ruptured or blocked artery starving or flooding the brain made sense only in a world where blood was understood to circulate. For establishing that apoplexy is fundamentally a vascular disease of the brain, Wepfer is rightly regarded as a founder of the scientific study of stroke.

Back to Table of Contents

Thomas Willis and the Circle of Willis

If Wepfer showed that apoplexy lived in the blood vessels, the English physician Thomas Willis (1621–1675) mapped the vessels themselves. In his landmark Cerebri Anatome (“Anatomy of the Brain”), published in 1664 with anatomical illustrations by the young Christopher Wren — later famous as the architect of St Paul’s Cathedral — Willis gave the most complete account to date of the brain’s structure and its arterial supply. The book is also where the word neurology was coined, and it earned Willis a lasting reputation as a father of that discipline.

Willis’s most enduring contribution to the stroke story is the structure that still bears his name: the circle of Willis (the circulus arteriosus cerebri), the ring of arteries at the base of the brain where the carotid and vertebrobasilar systems join. Earlier anatomists had glimpsed this anastomosis, but Willis described it most completely and, crucially, reasoned about its function — suggesting that this arterial ring could allow blood to reach the brain by an alternative route if one feeding vessel were blocked. That insight into collateral circulation remains central to how clinicians understand why some arterial blockages devastate the brain while others are partly compensated. (The eponym “circle of Willis” itself came into standard use later, in the eighteenth century, as his description was adopted as definitive.)

Willis worked at the height of the seventeenth-century scientific revolution, among the Oxford circle that helped found the Royal Society, and his collaboration with Wren, Richard Lower, and Thomas Millington exemplifies the new empirical anatomy. By giving physicians a clear picture of the brain’s blood supply and its built-in redundancy, Willis supplied the anatomical map onto which later workers — from Virchow to the modern neuroradiologist — would plot exactly where, and how, the circulation fails in a stroke.

Back to Table of Contents

Virchow: Thrombosis, Embolism, and the Modern Mechanism

The next great advance came from the German pathologist Rudolf Virchow (1821–1902), the founder of cellular pathology and one of the most influential physicians of the nineteenth century. Working in the 1840s and 1850s, Virchow gave precise meaning to two mechanisms that Wepfer had only sketched, and he supplied the vocabulary still used today: he is credited with coining and clearly defining the terms thrombosis (a clot forming in place within a vessel) and embolism (a clot or other plug that breaks loose, travels through the bloodstream, and lodges in a distant vessel). He introduced these terms in the mid-1840s and elaborated them in his collected pathological work of the 1850s and his Cellularpathologie of 1858.

Virchow’s key realisation was that a clot found blocking a brain artery had often not formed there at all. He showed that material could detach from a clot elsewhere in the body — for example from the heart or a diseased large artery — and be carried by the circulation until it wedged in and plugged a smaller cerebral vessel, killing the tissue downstream. This concept of thromboembolism explained how a problem in the heart or neck could cause sudden catastrophe in the brain, and it is the direct ancestor of the modern understanding of ischemic stroke. His associated analysis of the factors that promote clotting — later distilled into the triad of altered blood flow, vessel-wall injury, and increased clotting tendency — remains a cornerstone of how clinicians think about why clots form.

By Virchow’s death at the start of the twentieth century, the essential pathological picture of stroke was in place: apoplexy was a vascular event in which a brain artery either burst (hemorrhage) or was plugged by a thrombus or embolus (infarction). What remained missing was any way to tell which in a living patient, and any treatment that could change the outcome. Both would arrive, but not for the better part of a century.

Back to Table of Contents

From “Apoplexy” to “Stroke” and “CVA”

The everyday English word stroke long predates the modern science. It carries the same core image as the Greek apoplexia — that of being suddenly struck — but with an explicitly religious colouring: the victim was thought to have been hit by the hand of God or a bolt from heaven. According to the medical historian Francis Schiller, the earliest synonym recorded for “the stroke of the palsy” in the historical record of the English language, dated to 1599, is the “stroke of God’s hands.” The expression framed the sudden collapse as a divine blow, the patient seemingly felled by lightning or by the deliberate touch of providence.

For centuries “stroke” and “apoplexy” coexisted — one the plain English word, the other the learned medical term — and both gradually shed their supernatural connotations as the vascular understanding matured. In the twentieth century a new, deliberately mechanistic term was introduced: cerebrovascular accident (CVA), which entered medical usage around 1927. “Cerebrovascular accident” was meant to assert the vascular nature of the event and to retire the archaic, fatalistic overtones of “apoplexy.” Its three parts — cerebro- (brain), vascular (blood vessels), and accident (a sudden, unplanned event) — encode the consensus that Wepfer, Willis, and Virchow had built.

Modern usage has shifted again. Many clinicians now discourage “cerebrovascular accident” precisely because the word accident implies bad luck and unpredictability, whereas stroke is increasingly understood as a largely preventable consequence of treatable risk factors such as high blood pressure, atrial fibrillation, and atherosclerosis — and as a treatable emergency once it occurs. The preferred term today is simply stroke, often split into ischemic stroke and hemorrhagic stroke, with transient ischemic attack (TIA) for the warning “mini-stroke.” The very evolution of the words — from a god’s blow, to an accident, to a preventable and treatable vascular event — tracks the medical journey described on this page.

Back to Table of Contents

The Imaging Revolution: CT, MRI, and the Two Strokes

For nearly all of stroke’s history, the single most important question — is this a bleed or a blockage? — could not be answered in a living patient. The distinction Wepfer had drawn at the autopsy table in 1658 was invisible at the bedside, and it mattered enormously: a hemorrhagic stroke and an ischemic stroke can look almost identical in their symptoms, yet some treatments that help one can be catastrophic for the other. Until physicians could see inside the living skull, stroke care was largely supportive and the two strokes could not be reliably separated.

That changed in the 1970s with the arrival of computed tomography (CT), the X-ray-based cross-sectional scanner whose inventors, Godfrey Hounsfield and Allan Cormack, were awarded the Nobel Prize in 1979. For the first time, a CT scan of the head could rapidly and reliably distinguish bleeding in the brain (which shows up bright on CT) from the absence of bleeding, allowing clinicians to tell a hemorrhagic stroke from an ischemic one within minutes. Magnetic resonance imaging (MRI), and later diffusion-weighted MRI, added exquisite sensitivity to early ischemic injury, and CT and MR angiography let physicians see the blocked or ruptured vessel itself. Imaging turned the ischemic/hemorrhagic distinction from a post-mortem finding into a routine, life-or-death decision made in the emergency department.

This imaging revolution was the indispensable precondition for modern stroke treatment. A drug that dissolves clots is lifesaving in an ischemic stroke but can be lethal if given to someone whose brain is already bleeding; without a scan to rule out hemorrhage, such a treatment could never be used safely. By making the bleed-versus-blockage question answerable in real time, CT and MRI did not merely improve diagnosis — they opened the door to the first treatments capable of changing a stroke’s outcome.

Back to Table of Contents

Clot-Busters and “Time Is Brain”

The modern era of stroke as a treatable emergency began in the mid-1990s with intravenous thrombolysis — a clot-dissolving drug given through a vein. The pivotal study was the NINDS rt-PA Stroke Trial, conducted by the U.S. National Institute of Neurological Disorders and Stroke and published in 1995. It randomised 624 patients with acute ischemic stroke to receive either intravenous tissue plasminogen activator (tPA, alteplase) or placebo within three hours of symptom onset. Patients treated with tPA were significantly more likely to have little or no disability three months later: in the trial, the proportion achieving a favourable outcome rose by roughly 11 to 13 percentage points compared with placebo. On the strength of these results, the U.S. Food and Drug Administration approved alteplase for acute ischemic stroke in 1996 — the first treatment ever shown to improve outcomes from an acute stroke.

tPA works by accelerating the body’s own breakdown of fibrin, the protein mesh that holds a clot together, helping to reopen the blocked artery and restore blood flow before the starved brain tissue dies. Because it powerfully promotes bleeding, it can only be given to patients in whom a CT scan has excluded hemorrhage — which is precisely why the imaging revolution of the 1970s and 1980s had to come first. The narrow original treatment window (initially three hours from onset, later extended to up to 4.5 hours for selected patients) reflects the unforgiving biology of the disease.

That biology is captured in the field’s defining slogan: “time is brain.” During an ischemic stroke, brain cells deprived of blood die at a staggering rate — an estimated 1.9 million neurons per minute in a typical large-vessel stroke, by a widely cited calculation — so every minute of delay costs irreplaceable tissue and function. This urgency reshaped emergency medicine: dedicated stroke teams, “code stroke” protocols, ambulance pre-notification, and certified stroke centres all exist to shorten the time from symptom onset to treatment. Since the turn of the century, thrombolysis has been joined by mechanical thrombectomy — threading a catheter into the brain to physically remove a large clot — which a series of trials around 2015 established as transformative for major strokes, further widening the window in which the brain can be rescued.

Back to Table of Contents

Legacy: From Divine Blow to Treatable Emergency

The history of stroke is one of the clearest examples in medicine of a condition transformed from a mystery into a manageable disease. For most of human history a stroke was apoplexy — a sudden, inexplicable, usually fatal blow, blamed on excess phlegm, black bile, or the hand of God, and met with little more than bleeding, purging, and prayer. The patient was a victim of forces no one could see or touch. The modern picture — a specific artery in the brain that has burst or been blocked, diagnosable by a scan in minutes and treatable by drugs or devices that restore blood flow — is the cumulative achievement of named individuals working over four centuries.

The lineage is direct: Hippocratic physicians described the clinical syndrome; Wepfer in 1658 located it in the brain’s blood vessels and recognised both bleeding and blockage; Willis in 1664 mapped the cerebral circulation and its protective arterial ring; Virchow in the nineteenth century named and explained thrombosis and embolism; CT and MRI in the late twentieth century finally let physicians see the bleed or the blockage in the living patient; and the NINDS trial and FDA approval of tPA in 1995–1996, followed by thrombectomy, made acute stroke treatable for the first time. Each step built on the last, and each depended on the willingness to replace inherited authority with direct observation.

For readers today the practical lesson of this history is hopeful and urgent. Because stroke is now both preventable — through control of high blood pressure, treatment of atrial fibrillation, management of cholesterol and atherosclerosis, and avoidance of tobacco — and treatable when caught early, recognising the warning signs and acting fast genuinely saves brain tissue and lives. The old fatalism of “apoplexy” is no longer warranted: the sudden one-sided weakness, facial droop, slurred speech, or loss of vision that once seemed a divine sentence is, today, a call to phone emergency services immediately. The phrase time is brain is the modern inheritance of two thousand years of inquiry — and it is, above all, a message of hope.

Back to Table of Contents

Research Papers and References

The references below combine peer-reviewed historical scholarship on apoplexy and cerebrovascular disease with the landmark clinical trial that opened the modern treatment era, plus curated PubMed topic-search links into the historical and clinical literature. Historical primary texts (the Hippocratic corpus, Wepfer’s Historiae Apoplecticorum of 1658, and Willis’s Cerebri Anatome of 1664) are named in the article as historical sources rather than as modern citations. Each link opens in a new tab.

  1. Engelhardt E. Apoplexy, cerebrovascular disease, and stroke: historical evolution of terms and definitions. Dementia & Neuropsychologia. 2017;11(4):449–452. — doi:10.1590/1980-57642016dn11-040016
  2. Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. Journal of the Royal Society of Medicine. 2017;110(1):9–12. — doi:10.1177/0141076816680121
  3. Pound P, Bury M, Ebrahim S. From apoplexy to stroke. Age and Ageing. 1997;26(5):331–337. — doi:10.1093/ageing/26.5.331
  4. Karenberg A, Hort I. Medieval descriptions and doctrines of stroke: preliminary analysis of select sources. Journal of the History of the Neurosciences. 1998;7(3):174–185. — doi:10.1076/jhin.7.3.174.1855
  5. Karbowski K. Johann Jakob Wepfer (1620–1695): pioneer in the research of apoplexy and poisoning. Schweizerische Rundschau für Medizin (Praxis). — PubMed: Johann Jakob Wepfer and apoplexy
  6. Pearce JMS. Johann Jakob Wepfer (1620–95) and cerebral haemorrhage. Journal of Neurology, Neurosurgery & Psychiatry. 1997;62(4):387. — PubMed PMID: 9120455
  7. Pearce JMS. The circle of Willis: Thomas Willis (1621–1675). Journal of Neurology, Neurosurgery & Psychiatry. — PubMed: Thomas Willis and Cerebri Anatome
  8. Bayön Porras C, et al. Rudolf Virchow and the discovery of cerebral embolism. Stroke. 2021. — doi:10.1161/STROKEAHA.121.034443
  9. Bagot CN, Arya R. Virchow and his triad: a question of attribution. British Journal of Haematology. 2008;143(2):180–190. — doi:10.1111/j.1365-2141.2008.07323.x
  10. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine. 1995;333(24):1581–1587. — doi:10.1056/NEJM199512143332401
  11. Saver JL. Time is brain — quantified. Stroke. 2006;37(1):263–266. — doi:10.1161/01.STR.0000196957.55928.ab
  12. Thompson JE. The evolution of surgery for the treatment and prevention of stroke: the Willis Lecture. Stroke. 1996;27(8):1427–1434. — doi:10.1161/01.STR.27.8.1427
  13. History of apoplexy and stroke (general historical review literature) — PubMed: history of apoplexy and stroke
  14. Development of computed tomography and the imaging of acute stroke — PubMed: CT imaging and acute stroke

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents